The U.S. Food and Drug Administration (FDA) has licensed the drug aripiprazole (Abilify®) for the treatment of schizophrenia and bipolar disorder. When combined with antidepressants, it can be used to treat major depression. This medicine is believed to work by blocking or lessening the effects of certain chemicals in the brain, which makes it useful for such a wide range of conditions.
Aripiprazole is available in tablet and liquid forms, and also in a rapidly dissolving tablet (called Abilify Discmelt®) that does not need to be taken with water. The form your healthcare provider recommends will depend on various factors. Children, for example, may have an easier time with the liquid form.
(Click Aripiprazole for more information on this product, such as possible side effects, dosing guidelines, and what to do if you are pregnant or breastfeeding.)